Microvascular Complications and Associated Risk Factors in Patients with Type 2 Diabetes Mellitus in Al-Madinah Al-Munawara, Saudi Arabia

Author:

El-Alameey Inas R.1,Al-Abdudullatif Ghada A.1,A. Alqubali Rema1,Al-Mutairi Abeer A.1,D Alamri Rama1,S. Saed Raoum1

Affiliation:

1. 1Clinical Nutrition Department, College of Applied Medical Sciences, Taibah University, Al Madinah Al Munawara, Saudi Arabia.

Abstract

Background/ aim: Chronic hyperglycemia is a hallmark of the metabolic disorder diabetes mellitus, which also causes microvascular problems that cause morbidity, recurrent hospital stays, and death. Our study's objective is to determine the relationships between microvascular issues and risk factors in people with type 2 diabetes in Al-Madinah Al-Munawara. Subjects and Methods: In Al-Madinah Al-Munawara, 275 patients with type 2 diabetes participated in this descriptive cross-sectional study; 86 of them had microvascular complications. An online questionnaire was used to collect the data. The study covered all participants aged 20 to 65 years old. Incomplete data, patients suffering from COVID-19, chest infections, cancer, and pregnant women were excluded. Results: Microvascular complications affect 37.3% of the elderly (41–65 years old) and 63% of the young (20–40 years old). There is a significant association (p <0.05) between the age of the patients and various types of microvascular complications. Retinopathy and peripheral neuropathy were more common in males than females. There was a positive correlation between HbA1c levels and other variables such as serum cholesterol, hemoglobin, high blood pressure, and the number of hospitalizations. Age, gender, hypertension, and type of treatment have a significant positive effect on the appearance of microvascular complications (p <0.05). Conclusion: In our study, the age, gender, and type of treatment of participants were independent predictors of microvascular complications among type 2 diabetic patients. The risk of complications from DM in this country will be decreased by health education and raising awareness.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3